OTC HIV tests: 42% of at-risk survey respondents said they "likely" would use test-- NEJM.
This article was originally published in The Gray Sheet
Executive SummaryHOME HIV TESTS: 42% OF AT-RISK INDIVIDUALS SURVEYED WOULD "LIKELY" USE the test if it were approved by FDA for over-the-counter use, Kathryn Phillips, PhD, University of California-San Francisco, et al. note in a study published in the May 11 New England Journal of Medicine. The study found that 42% of 2,523 respondents to a national health survey who were deemed to be at risk for HIV said they would be "very or somewhat likely to use home tests" for the virus. Sixty-three percent of this group noted that they had never been tested for HIV, excluding testing for blood donations.
You may also be interested in...
Senate Finance Committee’s approach to penalize companies for raising WAC list prices is not a ‘price control,’ but a reasonable approach to change the incentives that distort pricing in the supply chain, US HHS Secretary Alex Azar says.
With the pre-GDUFA backlog largely acted upon, the FDA expects ANDA approvals to decrease, but supplement actions to increase in FY 2020 and FY 2021.
February and March inspections deferred unless any are deemed mission critical. China director remains behind as staff evacuate.